July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Clinical and molecular characterization of autosomal recessive and X-linked incomplete congenital stationary night blindness
Author Affiliations & Notes
  • Rola Ba-Abbad
    Moorfields Eye Hospital, London, United Kingdom
    UCL Institute of Ophthalomology, London, United Kingdom
  • Gavin Arno
    UCL Institute of Ophthalomology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Omar Abdul Rahman Mahroo
    UCL Institute of Ophthalomology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Michel Michaelides
    UCL Institute of Ophthalomology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Andrew Webster
    UCL Institute of Ophthalomology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Anthony G Robson
    Electrophysiology, Moorfields Eye Hospital, London, United Kingdom
    UCL Institute of Ophthalomology, London, United Kingdom
  • Footnotes
    Commercial Relationships   Rola Ba-Abbad, None; Gavin Arno, None; Omar Mahroo, None; Michel Michaelides, None; Andrew Webster, None; Anthony Robson, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5950. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rola Ba-Abbad, Gavin Arno, Omar Abdul Rahman Mahroo, Michel Michaelides, Andrew Webster, Anthony G Robson; Clinical and molecular characterization of autosomal recessive and X-linked incomplete congenital stationary night blindness. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5950.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe the clinical and electrophysiological features of incomplete congenital stationary night blindness (iCSNB) due to disease-causing variants in CACNA1F and CABP4.

Methods : Retrospective study assessing the clinical, molecular, and electrophysiological characteristics of retinopathy in patients with iCSNB, reviewed at Moorfields Eye Hospital. International-standard electroretinography (ERG) was performed under dark-adapted (DA) and light-adapted (LA) conditions, in patients with clinical signs and symptoms of retinal dysfunction. Patients with clinical diagnosis of iCSNB underwent molecular testing using next generation sequencing, whole exome, or whole genome sequencing.

Results : Thirty-seven patients were identified. Thirty-two patients (5–72 years) were hemizygous for variants in CACNA1F (23 nonsense or frameshift, 5 missense). Five patients (5-47 years) had bi-allelic variants in CABP4 (4 nonsense or frameshift, 1 deletion < 1 kb abolishing exon 6). Pediatric ERG protocols were used for 10 patients with CACNA1F retinopathy and one patient with CABP4 retinopathy, and were excluded from quantitative ERG analysis. Patients harboring CACNA1F variants had variable visual acuity (20/15-20/200), nystagmus (38%), myopia (53%) or hypermetropia (19%), nyctalopia (15%), and photoaversion (6%). All patients with CABP4 variants had severely reduced vision (20/200-20/500), nystagmus (80%), photoaversion (60%), and dyschromatopsia (60%). Retinal examination was unremarkable in either disorder. The DA 10 ERG a- and b-wave amplitudes overlapped between the CACNA1F and CABP4 groups; all had electronegative waveforms, but the range of b:a ratios in the CACNA1F cases (range 0.36 –1.01) extended to higher values than those for CABP4 (range: 0.4–0.58). The LA 3.0, single flash cone ERGs were smaller in the CABP4 group: a-wave, range 0–20 µV; b-wave range 0–30 µV, than some of the cases with CACNA1F-retinopathy: a-wave, range 10–60 µV; b-wave, range 15–65 µV.

Conclusions : The visual symptoms and retinal dysfunction in CABP4 retinopathy are more severe than in CACNA1F retinopathy, suggesting different roles of the two proteins in rod and cone systems.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×